Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Aug 28:39:50.
doi: 10.1186/1824-7288-39-50.

Antiepileptic drugs and breastfeeding

Riccardo Davanzo  1 , Sara Dal Bo, Jenny Bua, Marco Copertino, Elisa Zanelli, Lorenza Matarazzo
Affiliations

Antiepileptic drugs and breastfeeding

Riccardo Davanzo et al. Ital J Pediatr. .

Abstract

Introduction: This review provides a synopsis for clinicians on the use of antiepileptic drugs (AEDs) in the breastfeeding mother.

Methods: For each AED, we collected all retrievable data from Hale's "Medications and Mother Milk" (2012), from the LactMed database (2013) of the National Library of Medicine, and from a MedLine Search of relevant studies in the past 10 years.

Results: Older AEDs, such as carbamazepine, valproic acid, phenytoin, phenobarbital, primidone are considered to have a good level of safety during lactation, due to the long term clinical experience and the consequent amount of available data from the scientific literature. On the contrary, fewer data are available on the use of new AEDs. Therefore, gabapentin, lamotrigine, oxcarbazepine, vigabatrin, tiagabine, pregabalin, leviracetam and topiramate are compatible with breastfeeding with a less documented safety profile. Ethosuximide, zonisamide and the continue use of clonazepam and diazepam are contraindicated during breastfeeding.

Conclusions: Although the current available advice on the use of AEDs during breastfeeding, given by different accredited sources, present some contradictions, most AEDs can be considered safe according to our review.

PubMed Disclaimer

References

    1. Hale TW. Medications and Mother’s milk 2012. 15. 1712 N Forest Amarillo TX: A Manual of Lactational Pharmacology; 2012. pp. 79106–7017. Pages 184-186, 264-265, 325-326, 426-427, 495-496, 651-653, 664-665, 870-871, 905-906, 910-911, 938-939, 940-941, 1077, 1091-1092, 1126-1127, 1136-1137, 1161-1162.
    1. Section on Breastfeeding. Breastfeeding and the use of human milk: an analysis of the American Academy of Pediatrics. Pediatrics. 2012;129(3):e827–841. - PubMed
    1. WHO. Collaborating centre for drug statistics methodology, Norwegian institute of public health. Olso: Guidelines for ATC classification and DDD assignment; 2012. pp. 15–21.
    1. Atkinson HC, Begg EJ, Darlow BA. Drugs in human milk. Clinical pharmacokinetic considerations. Clin Pharmacokinet. 1988;14(4):217–40. - PubMed
    1. Ip S, Chung M, Raman G, Trikalinos TA, Lau J. A summary of the agency for healthcare research and quality’s evidence report on breastfeeding in developed countries. Breastfeed Med. 2009;4(Suppl 1):S17–30. - PubMed

Substances